Stocks are continuing to pause, which is constructive. One area of potential concern could be the small caps, which posted an outsized decline even though the 10-year yield continued to back off. Axon stock broke out on earnings, while Eli Lilly jumped on drug approval news. Dell is continuing to hold in a buy range with a bullish relative strength line.
